NCT02584478 2023-11-08
AL3818
Advenchen Laboratories, LLC
Phase 3 Unknown
Clinical Trials
29 trialsNCT04201561 2023-06-26
SELENIUM
Seoul National University Hospital
Phase 3 Unknown
NCT00326456 2023-03-27
MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer
National Cancer Institute, Naples
Phase 3 Unknown
NCT00660842 2023-03-24
MITO-7
National Cancer Institute, Naples
Phase 3 Unknown
NCT01802749 2023-03-24
MITO16MANGO2b
National Cancer Institute, Naples
Phase 3 Unknown
NCT03278717 2022-09-27
ICON9
University College, London
Phase 3 Unknown
NCT05043402 2022-08-15
A Study of Navicixizumab in Patients With Platinum Resistant Ovarian Cancer
OncXerna Theraputics, Inc.
Phase 3 Unknown
NCT04229615 2022-04-25
A Study of Fluzoparib±Apatinib Versus Placebo Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on First-Line Platinum-Based Chemotherapy
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Unknown
NCT05244811 2022-02-17
Treat of Functional Ovarian Cysts by Compare Between Cocs and Progesterone Only Pills
Sohag University
Phase 3 Unknown
NCT00954174 2021-09-30
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer
GOG Foundation
Phase 3 Unknown
NCT04679064 2021-08-27
NItCHE-MITO33
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 3 Unknown
NCT01611766 2021-06-10
Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)?
Shanghai Gynecologic Oncology Group
Phase 3 Unknown
NCT03709316 2021-06-02
A Study of ZL-2306 (Niraparib) as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer
Zai Lab (Hong Kong), Ltd.
Phase 3 Unknown
NCT04337632 2021-04-08
Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian Cancer
Hunan Cancer Hospital
Phase 3 Unknown
NCT04473339 2020-09-09
A Randomized Prospective Trail of HIPEC in Recurrent Ovarian Cancer Patients With HRR Mutation
Zhongnan Hospital
Phase 3 Unknown
NCT03371693 2020-05-29
HIPECOV
Zhongnan Hospital
Phase 3 Unknown
NCT03693248 2019-12-10
ROCOCO
Seoul National University Hospital
Phase 3 Unknown
NCT04000295 2019-10-08
Apatinib and Etoposide Capsule Versus Weekly Paclitaxel in Patients With Platinum Resistant Ovarian Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Unknown
NCT00532194 2015-09-23
ICON6
Medical Research Council
Phase 3 Unknown
NCT01628380 2014-08-28
CHORINE
A.O. Ospedale Papa Giovanni XXIII
Phase 3 Unknown
NCT00002477 2013-12-18
Adjuvant Chemotherapy Compared With Observation in Treating Patients With Resected Early Stage Ovarian Epithelial Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT02011659 2013-12-13
PONV
National Health Insurance Service Ilsan Hospital
Phase 3 Unknown
NCT00004115 2013-09-17
Monoclonal Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal Cancer in Remission Following Surgery and Chemotherapy
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00274950 2013-09-17
Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors
National Cancer Institute (NCI)
Phase 3 Unknown
NCT01654146 2012-07-31
ICON8
Medical Research Council
Phase 3 Unknown
NCT01087268 2011-07-15
Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00726635 2009-02-17
The Assessment of Preoperative Psychological Intervention on Stress in Women With Gynecological Malignancies
Rabin Medical Center
Phase 3 Unknown
NCT00715286 2008-07-15
Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Phase III Randomized Study
All India Institute of Medical Sciences
Phase 3 Unknown
NCT00533299 2007-09-21
Hydralazine Valproate for Ovarian Cancer
National Institute of Cancerología
Phase 3 Unknown